These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 4812201)

  • 1. Some of the less known side effects of Rifampin in therapy of tuberculosis.
    Nair SV; Kass I
    Nebr Med J; 1974 Feb; 59(2):42-3. PubMed ID: 4812201
    [No Abstract]   [Full Text] [Related]  

  • 2. Side effects during intermittent rifampicin and ethambutol treatment. A preliminary report.
    Guerra Sanz FJ
    Scand J Respir Dis Suppl; 1973; 84():160-5. PubMed ID: 4522071
    [No Abstract]   [Full Text] [Related]  

  • 3. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) II. Side effects].
    Girling DJ
    Bull Int Union Tuberc; 1974; 49(1):451-5. PubMed ID: 4619567
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombocytopenia--a rare but serious side effect of rifampicin.
    Shah NM; Venkatachalam S; Mehta Y; Balakrishnan C; Dubey SG; Mangat GK; Joshi VR
    J Assoc Physicians India; 1996 May; 44(5):359-60. PubMed ID: 9282598
    [No Abstract]   [Full Text] [Related]  

  • 5. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dynamics of various immunobiochemical and encephalographic indices during polychemotherapy of pulmonary tuberculosis patients].
    Sagalovich VIa; Medunitsyna ND; Andrzheiuk NI; Chelnokova NV; Sagalovich AV
    Probl Tuberk; 1982 Feb; (2):36-41. PubMed ID: 7063477
    [No Abstract]   [Full Text] [Related]  

  • 7. [Systemic collateral effects of intermittent antituberculous treatments with rifampicin].
    Decroix G; Pujet JC
    Rev Tuberc Pneumol (Paris); 1971 Nov; 35(7):733-43. PubMed ID: 5151216
    [No Abstract]   [Full Text] [Related]  

  • 8. Pseudomembranous colitis in a patient on rifampicin and ethambutol.
    Moriarty HJ; Scobie BA
    N Z Med J; 1980 Apr; 91(658):294-5. PubMed ID: 6930008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Liver and kidney damage in rifampicin and ethambutol treatment].
    Kozma D; Mihalik P
    Z Erkr Atmungsorgane; 1984; 162(3):249-55. PubMed ID: 6485386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hematological abnormalities during treatment with rifampicin].
    Lebacq E; Taminau E
    Lille Med; 1974 Mar; 19(3):269-71. PubMed ID: 4437277
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of tuberculosis in the adult].
    Schrappe M; Wassermann K; Kroegel C
    Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936
    [No Abstract]   [Full Text] [Related]  

  • 12. [Side effects of antitubercular drugs leading to discontinuation of drug therapy].
    Bergan S; Laake K; Bjartveit K
    Tidsskr Nor Laegeforen; 1980 Feb; 100(5):279-82. PubMed ID: 7385151
    [No Abstract]   [Full Text] [Related]  

  • 13. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
    Engbaek HC; Heckscher T; Højgaard C; Larsen SO; Rasmussen KN; Vergmann B
    Eur J Respir Dis; 1982 Mar; 63(2):84-93. PubMed ID: 7040100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Case of fatal liver failure due to anti-tuberculous therapy].
    Harada Y; Kawakami K; Koyama K; Yamaryo T; Kimura Y
    Kekkaku; 2007 Sep; 82(9):705-9. PubMed ID: 17969987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethambutol-induced thrombocytopenia.
    Rabinovitz M; Pitlik SD; Halevy J; Rosenfeld JB
    Chest; 1982 Jun; 81(6):765-6. PubMed ID: 7075316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: Rifampin in the treatment of tuberculosis.
    Grzybowshi S
    Can Med Assoc J; 1974 May; 110(9):1002 passim. PubMed ID: 4823101
    [No Abstract]   [Full Text] [Related]  

  • 18. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK; Stead WW
    Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rifampicin and ethambutol combination in the treatment of pulmonary tuberculosis. Partial results].
    Ennes Filho E; Azevedo DE; Sayeg F
    Rev Bras Med; 1971 Apr; 28(4):171-9. PubMed ID: 5120854
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of life-threatening thrombocytopaenia in a patient on MDT and prednisolone.
    Croft R
    Lepr Rev; 1996 Sep; 67(3):229. PubMed ID: 8885619
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.